Explained herein are pharmaceutical packaging units which avert oxidative degradation of morphine, hydromorphone, promethazine and also other oxygen-sensitive medicines, such methods including a syringe using an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with extremely small permeability to oxygen and comprises